ATP Testing Market Worth $412 Million by 2027

0

CHICAGO, April 7, 2022 /PRNewswire/ — According to new market research report ATP Testing Market by Product (Consumables (Kits, Reagents, Microplates), Instrument (Luminometer, Spectrophotometers)), Application (Contamination, Disease Testing, Drug Discovery), End User (Hospitals, Pharmaceuticals, Food Testing) – Global Forecast to 2027″, published by MarketsandMarkets™, the global market is expected to reach $412 million by 2027 from $276 million in 2022, at a CAGR of 8.4%.

Browse the in-depth table of contents at “ATP Testing Market”
158 – Tables
46 – Numbers
226 – Pages

Download the PDF brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=223438780

Growing incidence of chronic and infectious diseases, increase in drug discovery and development studies, favorable regulatory guidelines, increasing focus of global market players on emerging Asian economies, increase in funding for research, increased investments by pharmaceutical and biotechnology companies and the modernization of research infrastructures are some of them. key factors driving the ATP assays market.

The pandemic has slightly affected ATP testing around the world. This disrupted the commodity supply chain, but after a few months the market rebounded again. The COVID-19 pandemic has restricted the movement of people, goods and services around the world, disrupted supply chains, limited sales operations, marketing efforts and field support, and hampered shipping and delivering products to customers. Due to high expenditure on research and increase in drug discovery post COVID-19, ATP assays are used to measure cytotoxicity and cell viability which will drive the growth of the ATP assay market in pharmaceutical companies and biotechnology and research laboratories.

The consumables and accessories segment accounted for the largest share of ATP assays, by product in 2021

On the basis of product, the ATP testing market is segmented into consumables and accessories and instruments. The large share of the consumables and accessories segment is attributed to the extensive use of ATP assays in research institutes to measure cell viability, increase in drug discovery due to an increase in chronic diseases that require tumor tests and cell proliferation (in cancer), and the repeated purchase of consumables by pharmaceutical and biotechnology companies.

Request sample pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=223438780

Contamination testing segment accounted for the largest share of the ATP testing market in 2021

Based on application, the market is segmented into contamination testing, disease testing, and drug discovery and development. The large share of the contamination testing segment can be attributed to the increasing regulatory stringency of pharmaceutical and food and beverage companies for uncontaminated production, an increase in drug discovery post COVID-19, and the need for surface cleaning and disinfection. environment in hospitals.

The segment of pharmaceutical and biotechnology companies accounted for the largest share of the ATP testing market in 2021

On the basis of end users, the market is segmented into pharmaceutical and biotechnology companies, food industry, hospitals and diagnostic laboratories, and academic and research institutes. The large share of the pharmaceutical and biotechnology segment can be attributed to the presence of a large number of pharmaceutical players with growing investments in this market, growing regulatory approvals for cell culture-based vaccines that require the use of tests ATP in contamination testing, expansion of various pharmaceutical companies, growing demand for cell and gene therapies for chronic diseases, significant R&D in pharmaceutical and biopharmaceutical companies, increased production of COVID-19 drugs, the growing adoption of cell-based assays for drug development and the ease of use of ATP assays in contamination testing.

Talk to the analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=223438780

North America accounted for the largest share of the ATP testing market in 2021

In 2021, North America accounted for the largest market share, followed by Europe, Asia Pacific, Latin Americaand the Middle East & Africa. The large part of North America can be attributed to the region’s large pharmaceutical and biotechnology industry, growing demand for cellular analyzes in research, growing food safety concerns, and increased government funding for life science research .

Key players in the ATP Assay market are Thermo Fisher Scientific, Inc. (US), Promega Corporation (US), Merck KGaA (Germany), PerkinElmer, Inc. (USA), Agilent Technologies, Inc. (USA), Abcam plc (UK), Lonza Group (Swiss), NEOGEN Corporation (USA), 3M (USA), Danaher Corporation (USA), PromoCell GmbH (Germany), Geno Technology, Inc. (USA), Abnova Corporation (Taiwan), AAT Bioquest (USA), BioThema AB (Sweden), Elabscience Biotechnology Inc. (USA), MBL International Corporation (USA), Biotium (USA), Creative Bioarray (USA), Canvax Biotech SL (Spain), Ruhof Corporation (USA), Charm Sciences, Inc. (USA), Bio Shield Tech LLC (USA), Cayman Chemical (USA) and Cell Signaling Technology (USA).

Browse adjacent markets: Market research reports and advice on analytical and scientific instrumentation

Browse related reports:

cell culture market by product (consumables (medium, serum, reagent, vessels), equipment (bioreactor, centrifuge, incubator)), application (vaccines, mAbs, diagnostics, tissue engineering), end user (pharmaceutical, biotechnology, hospital) – Global forecast up to in 2026
https://www.marketsandmarkets.com/Market-Reports/cell-culture-market-media-sera-reagents-559.html

Cell Therapy Technology Market by product (consumables, equipment (single-use equipment, other equipment), systems and software), process (cell processing), cell type (T cells, stem cells), end user (research institutes) – Global forecast up to in 2025
https://www.marketsandmarkets.com/Market-Reports/cell-therapy-technologies-market-213334978.html

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats that will impact 70%-80% of global business revenue. Currently serving 7,500 customers worldwide, including 80% of global Fortune 1000 companies as customers. Nearly 75,000 senior executives from eight industries around the world approach MarketsandMarkets™ for their revenue decision issues.

Our 850 full-time analysts and MarketsandMarkets™ SMEs track global high-growth markets by following the “Growth Engagement Model – GEM”. The GEM aims for proactive collaboration with customers to identify new opportunities, identify most important customers, write “Attack, Avoid and Defend” strategies, identify additional sources of revenue for the company and its competitors. MarketsandMarkets™ now offers 1,500 MicroQuadrants (positioning top performers among Leaders, Emerging Companies, Innovators, Strategic Players) each year in high-growth emerging segments. MarketsandMarkets™ is determined to benefit over 10,000 companies this year for their revenue planning and help them bring their innovations/disruptions to market by providing research ahead of the curve.

MarketsandMarkets’ flagship competitive intelligence and market research platform, “Knowledge Store”, connects over 200,000 markets and entire value chains for a deeper understanding of unmet information, as well as market sizing and niche market forecasts.

Contact:
Mr. Aashish Mehra MarketsandMarkets™ INC.
630 Dundee Road
Office 430
Northbrook, IL 60062
UNITED STATES: +1-888-600-6441
E-mail: [email protected]
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/atp-assay-market.asp
Visit our website: https://www.marketsandmarkets.com
Source of content: https://www.marketsandmarkets.com/PressReleases/atp-assay.asp

SOURCE Markets and Markets

Share.

Comments are closed.